Cipta Sarana Medika Tbk. vs Cerestar Indonesia Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Cerestar Indonesia Tbk. trades at Rp165 (market cap 1.29T, 196.6K 24h volume). The key difference: Cerestar Indonesia Tbk. is far larger — about 8.2× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 196.6K). Which is the better fit depends on your goals.
| DKHH | TRGU | |
|---|---|---|
Market Cap | 158.12B | 1.29T |
Volume | 8.21M | 196.6K |
Lot | 82.15K | 1.97K |
Turnover | 515.2M | 31.18M |
Average Price | 62.72 | 158.59 |
Value | 515.2M | 31.18M |
Indicative Equilibrium Price | 63 | 165 |
Indicative Equilibrium Volume | 1.33K | 65 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT. Cerestar Indonesia Tbk (the Company) was established based on Notarial Deed No. 2 datedAugust 30, 2020 of Dwi Yulianti, S.H., notary in Jakarta The Company started its commercial operations in 2021.
Read more on TRGU →